IPSC as of Oct 31 · 17:49 ET
IPSCNasdaqBiological Products, (No Diagnostic Substances)

Century Therapeutics, Inc. · Brief

Next report

12 days

Nov 12 · before openest.Q3 FY26

Expected move

Inputs

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±29.8%▼−4.85%×0.16
quarterimplied−30%0+30%realized×
Q2 FY26±29.8%▼−4.85%×0.16
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 12 report · est.

Bull2 of 3

7disclosed supplier and customer relationships listed in SEC filingsSEC filings
100managers reporting a position in the most recent quarterly filings13F · Jun 30 '26

Bear2

4 of 23largest reporting managers that reduced their stake in the latest quarter13F · Jun 30 '26
16managers whose positions together constitute four fifths of reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

IPSC report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 29impliedImplied move: ±62.6% into Nov 12 earnings (Oct 29 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.